BRAF and melanoma: • Pilot study to examine exosomes collected from the blood before and after BRAF inhibitor therapy in patients with advanced unresectable or metastatic BRAF mutation-positive melanoma • To develop an exosome-based theranostic tool for personalized care in melanoma patients